Fiche centre
SCRI Oncology Partners ( Site 7000)
Nashville — United States
Essais liés4clinical trials
VilleNashvillelocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL
Informations
centreSynchronisé depuis ClinicalTrials.gov — NCT07227597
Essais cliniques associés
4| Molécule | Indication / population | Phase | NCT | Titre | Statut |
|---|---|---|---|---|---|
| Gocatamig | Cancer | Phase 1/2 | NCT07227597 | A Clinical Study of Gocatamig (MK-6070) and Infinatamab Deruxtecan (MK-2400) in People With Small Cell Lung Cancer (MK-6070-003) | RECRUITING |
| Pembrolizumab | Cancer | Phase 3 | NCT06393374 | Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) | RECRUITING |
| Opevesostat | Cancer | Phase 3 | NCT06136624 | OMAHA-003 — Study of Opevesostat (MK-5684) Versus Alternative NHA in mCRPC (MK-5684-003) | RECRUITING |
| MK-1045 | Cancer | Phase 2/3 | NCT07634471 | A Clinical Trial of MK-1045 and Rituximab in People With Follicular Lymphoma (MK-1045-007) | RECRUITING |